A Phase II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer
Phase of Trial: Phase II
Latest Information Update: 25 May 2017
At a glance
- Drugs Sapanisertib (Primary)
- Indications Thyroid cancer
- Focus Therapeutic Use
- 28 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 14 May 2015 Planned initiation date changed from 1 Oct 2014 to 1 Jul 2015, as reported by ClinicalTrials.gov.
- 23 Sep 2014 New trial record